Publicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Valencia (8)

2018

  1. Dexamethasone preconditioning in cardiac procedures reduces decreased antithrombin activity and is associated to beneficial outcomes: Role of endothelium

    Frontiers in Pharmacology, Vol. 9, Núm. SEP

2015

  1. Glucocorticoids as modulators of expression and activity of Antithrombin (At): Potential clinical relevance

    Thrombosis Research, Vol. 135, Núm. 1, pp. 183-191

2013

  1. Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: Relationship to clinical status

    Life Sciences, Vol. 93, Núm. 2-3, pp. 108-115

  2. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1833, Núm. 10, pp. 2322-2333

2012

  1. Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure ethiology and correlates to clinical variables

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 303, Núm. 3, pp. 368-376

2010

  1. The impact of α1-adrenoceptors up-regulation accompanied by the impairment of β-adrenergic vasodilatation in hypertension (The Journal of Pharmacology and Experimental Therapeutics (2009) 328, (982-990))

    Journal of Pharmacology and Experimental Therapeutics

  2. β-Adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion

    Journal of Hypertension, Vol. 28, Núm. 6, pp. 1281-1289

2009

  1. The Impact of α1-Adrenoceptors Up-regulation accompanied by the mpairment of β-adrenergic vasodilatation in hypertension

    Journal of Pharmacology and Experimental Therapeutics, Vol. 328, Núm. 3, pp. 982-990